1. Finasteride reduces the risk of developing prostate cancer overall, but increases risk for high-grade prostate cancer.
2. Finasteride neither increased nor decreased overall survival or prostate cancer survival.
Evidence Rating Level: 2 (Good)
Study Rundown: The Prostate Cancer Prevention Trial (PCPT), published in 2003, showed that finasteride reduces the risk...